DDIT3 and diffuse large B-cell lymphoma: Because of our small sample size, we used the microarray data published by Lenz et al. as an additional independent cohort (n = 200 of patients treated with R-CHOP and assigned to the subtype ABC-DLBCL or GCB-DLBCL [21]).